Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy

British Journal of Cancer

Volumn 75, Issue 5, 1997, Pages 722-728

  Arends, M J ^a   Benton, E C ^b   McLaren, K M ^a   Stark, L A ^c   Hunter, J A A ^b   Bird, C C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c NONE

Author keywords

Human papillomavirus; Immunocytochemistry; Intraepidermal carcinoma; Keratoses; p53; Polymerase chain reaction; Renal allograft recipient; Skin neoplasia; Southern hybridization; Squamous cell carcinoma; Viral wart

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; HUMAN; HUMAN TISSUE; KERATOSIS; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM; VERRUCA VULGARIS; WART VIRUS;

EID: 0031040163     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.128     Document Type: Article

References (47)

1. Alloub MI, Barr BBB, McLaren KM, Smith IW, Bunney MH and Smart GE (1989) Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. Br Med J 298: 153 156
2. Arends MJ, Wyllie AH and Bird CC (1990) Papillomaviruses and human cancer Hum Pathol 21: 686-698
3. Arends MJ, Donaldson YK, Duvall E, Wyllie AH and Bird CC (1991) HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR assay. J Pathol 165: 301-309
4. Arends MJ, Donaldson YK, Duvall E, Wyllie AH and Bird CC (1993) HPV 18 associates with more advanced cervical neoplasia than HPV 16. Hum Pathol 24: 432-437
5. Arends MJ, Wyllie AH and Bird CC (1995) HPV 18 is associated with less apoplosis in fibroblast tumours than HPV 16. Br J Cancer 72: 646-649
6. Banks L, Matlashewski G and Crawford L (1986) Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159: 529-534
7. Barr BBB, McLaren KM, Smith IW, Benton EC, Bunney MH, Blessing K and Hunter JAA (1989) Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1: 124-128
8. Benton EC, Arends MJ (1996) Human papillomavirus in the immunosuppressed In: Papillomavirus Reviews: Current Research on Papillomaviruses Lacey C. (ed.), pp. 271-279. Leeds University Press: Leeds
9. Berkhout RJM, Tieben LM, Smits HL, Bouwes-Bavinck JN, Vermeer BJ and ter Schegget J (1995) Nested PCR approach for detection and typing of Epidermodysplasia Verruciformis-associated human Papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33: 690-695
10. Blessing K, McLaren KM, Benton EC, Barr BB, Bunney MH, Smith JW and Beveridge GW (1989) Histopathology of skin lesions in renal allograft recipients - an assessment of viral features and dysplasia Histopathology 14: 129-139
11. Blessing K, McLaren KM, Morris R, Barr BBB, Benton EC, Alloub M, Bunney MH, Smith IW, Smart GE and Bird CC (1990) Detection of human papillomavirus in skin and genital lesions of renal allograft recipients by in situ hybridisation. Histopathology 16: 181-185
12. Bouwes-Bavinck JN, Gissmann L, Claas FHJ, Van der Woude EJ, Persijn GG, Schegget JT, Yermeer BJ, Jochmus I, Muller M, Steyer G, Gebert S and Pfister H (1993) Relation between skin cancer, humoral responses to human papillomaviruses and HLA class II molecules in renal transplant recipients. J Immunol 151: 1579-1586
13. Bunney MH, Benton EC, Barr BBB, Smith IW, Anderton JL and Hunter JAA (1990) The prevalence of skin disorders in renal allografl recipients receiving cyclosporin A compared with those receiving azathioprine. Nephrol Dial Transplant 5: 379-382
14. Dyall-Smith D, Trowell H, Mark A and Dyall-Smith M (1991) Cutaneous squamous cell carcinoma and papillomaviruses in renal transplant recipients: a clinical and biological study. J Dermatol Science 2: 139-146
15. Eliezri YD, Silverstein SJ and Nuova GJ (1990) Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasms. J Am Acad Dermatol 23: 836-842
16. Ellis JRM, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS and Stern PL (1995) The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Med 1: 464-470
17. Euvrard S, Chardonnet Y, Dureau G, Hermier C and Thivolet J (1991) Human papillomavirus type I-associated squamous cell carcinoma in a heart transplant recipient. Arch Dermatol 127: 559-564
18. Holgate CS, Jackson P, Pollard K, Lunny D and Bird CC (1986) Effect of fixation on T and B lymphocyte surface membrane antigen demonstration in paraffin processed tissue. J Pathol 149: 293-300
19. Kelly GE, Sheil AGR, Rose BR, Caterson R, Pearse E, Thompson CH and Cossart YE (1992) HPV infection in the lower genital tract of women undergoing haemodialysis and women with renal allografts. Clin Transplant 5: 7-12
20. Leigh LM and Glover MF (1995) Cutaneous warts and tumouts in immunosuppressed patients. J Royal Soc Med 88: 61-62
21. London NJ, Farmery SM, Will EJ, Davison AM and Lodge JPA (1995) Risk of neoplasia in renal transplant patients. Lancet 346: 403 406
22. Lutzner M, Croissant O, Ducasse MF, Kreiss H, Crosnier J and Orth G. (1980) Potentially oncogenic human papillomavirus (HPV 5) found in two renal allograft recipients. J Invest Dermatol 75: 353 357
23. Lutzner MA, Orth G. Dutronquay V, Ducasse M-F, Kreiss H and Crosnier J (1983) Detection of luiman papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet 2: 422-424
24. McGregor JM, Farthery A, Cook T, Yu CC, Dublin EA, Levison PA and McDonald DM (1994) Post transplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomavirus. J Am Acad Dermatol 30 (5): 701 706
25. Müller M. Kelly G. Fiedler M and Gissman L (1989) Human papillomavirus type 48. J Virology 63, 4907 4908
26. Ogunbiyi OA, Scholefied JH, Faffery AT Smith JHF, Duffy S, Sharp F and Rogers K (1994) Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allogaft recipients. Br J Surg 81: 365-367
27. Oilli G, (1987) Epidemiodysplasia variucilormis. In Flu Papinaviridae. Vol. 2. The Papillomaviruses Salzmar NP and Howley PM (eds). pp. 199 243 Plenum: New York
28. Plister H (1992) Haman papillomasvirus and skin cancer. Seminars in Cancer Biology 3 263-271
29. Paidie CA, O'Grady J, Pais I, Wyllie NH and Blid CC (1991) P53 expression in colotectal tumours. Am J Pathol 138: 807 813
30. Radlinger R and Grob R (1998) Papillomavirus infection and skin cancer in renal allograft recipients Lancet 1: 1132-1133
31. Sambrook J, Fritsch EF and Mamatis T (1989) Molecular Cloning. A Laboratory Manual. 2nd edn, pp. E3 E4, Cold Spring Harbor Laboratory Press: Cold Spring Harbor. NY.
32. Shamanin V, Glover M, Ranscb C, proby C, Leigh IM, zur Hausen H and Villiers E-M (1994) Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in the immunosuppressed. Cancer Res 54: 4610-13
33. Shamaninn V, zur Hausen H, Lavergne D, Proby C, Leigh I, Neumann C, Hamm H, Goos M, Haustein U-F. Jung EG, Plewig G, Wolff H and de Villiers E-M (1996) Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst 88: 802 811
34. Smith SE, Davis IC, Leshin B, Fleisher AD, White WL and Feldman SR (1993) Absence of human papillomavirus in squamous cell carcinomas of non genital skin from immunocompromised renal transplant patients. Arch Dermatol 129: 1585-1588
35. Soler C, Chardonnet Y, Envard S, Chignol MC and Thivolet J (1992) Evaluation of human papillomavirus type 5 on trozen sections of multiple lesions from transplant recipient with in situ hybridisation and non isotopic probes. Dermatology 184: 248 253
36. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA and Bird CC (1994a) Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 69: 222-229
37. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA and Bird CC (1994b) Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients. Br J Cancer 70: 662 -667
38. Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Bruijn JA. van der Woudes FJ and Ter Schegget J (1994) Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients, Br J Dermatol 131: 226-230
39. Tieben LM, Berkhout JM, Smits HI., Bouwes Bavinck JN, Vernieer BJ, van der Woudes FJ and Ter Schegget J (1995) High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 105: 367 371
40. Van der Leest RL, Zachow KR, Ostrow RS Bender M, Pass F and Faras AJ (1987) Human papillomasvirus heterogyrieity in 36 renal transplant patients Arch. Dermatol 123: 354 357
41. Vojtesek B, Bartek J, Midgley CN and Lane DP (1992) An immunochemical analysis of the haman nuclear phosphoprotein p53 new microclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237 244
42. Wank R and Tomssen C (1991) High risk of squamous cell carcinoma of the cerviv for women with HLA-DQw3. Nature 723: 723 725
43. Wright DK and Manos MM (1990) Sample preparation from paraffin-embedded. tissues. In PCR Protocols: a Guide to Methods and Applications, Innis MA, Gelfand DH, Sninsky JJ and White TJ (eds). pp. 153 158. Academic Press: San Diego
44. Yoshikawa T, Rae U and Bruins-Slott W (1990) Susceptibility to effects UV radiation on induction of contact hypersensitivity as a risk factor skin cancer in humans. J Invest Dermatol 95: 530-536
45. zur Hausen H (1986) Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events. Lancet 2: 1370 1372
46. zur Hausen H (1994) Molecular pathogensis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186: 131 156
47. zur Hausen H (1995) Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervis. Lancet 343: 955 957